Literature DB >> 7390639

Demonstration and quantification oomycosis.

L Yarzábal, J P Dessaint, M Arango, M C de Albornoz, H Campins.   

Abstract

Using a radioimmunoassay technique, we have determined the total IgE concentration and specific IgE antibody level against Paracoccidioides brasiliensis in the sera of patients with mycologically confirmed active paracoccidioidcosis. Patients with aspergilloma, or individuals with antibodies against Cadida albicans, and sera of apparently healthy individuals from the endemic area were also examined. The level of total IgE was significantly elevated in 9 out of 10 cases of paracoccidioidomycosis. The mean level of specific IgE against P. brasiliensis was significantly higher in the serum of the patients in comparison with control individuals. The percentage of specific IgE relative to the total varied from 0.38 to 2.28%. The differences between IgE levels in pare other mycoses were statistically significant. Our results suggest a possible involvement of specific IgE antibodies against P. brasiliensis in the immune response of patients with paracoccidioidomycosis. The hyperimmunoglobulinemia E may be related to the T-cell defect that characterizes the severe forms of the disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7390639

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Effect of anti-IL-4, interferon-gamma and an antifungal triazole (SCH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome.

Authors:  J S Hostetler; E Brummer; R L Coffman; D A Stevens
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

2.  T-cell dysfunction and hyperimmunoglobulinemia E in paracoccidioidomycosis.

Authors:  M Arango; L Yarzábal
Journal:  Mycopathologia       Date:  1982-08-20       Impact factor: 2.574

Review 3.  Paracoccidioidomycosis: an update.

Authors:  E Brummer; E Castaneda; A Restrepo
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.